HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed) | RFA DA 21 020

Opportunity Information: Apply for RFA DA 21 020

The HEAL Initiative: HEALthy Brain and Child Development (HBCD) Study grant opportunity (RFA-DA-21-020) is a National Institutes of Health (NIH) cooperative agreement (U01) focused on building a large, diverse, long-term research cohort to better understand how substance exposure during pregnancy and around the time of birth affects children as they grow. The core goal is to recruit pregnant participants and follow mother-infant pairs for a full decade, generating high-quality, standardized data that can clarify how early exposures and life circumstances shape a child's brain development, physical health, and behavior over time. Although this is a major, multi-year human study, the funding notice specifies "Clinical Trial Not Allowed," meaning applicants should propose an observational, longitudinal cohort design rather than testing an intervention for efficacy.

The study design NIH is seeking centers on enrolling pregnant women starting in the second trimester, continuing recruitment through delivery, and then tracking outcomes in the offspring through childhood for 10 years. The cohort is explicitly intended to include infants with pre- or perinatal exposure to a range of commonly used substances, including prescription and illicit opioids, marijuana, stimulants, alcohol, and nicotine. By intentionally including these exposure groups and following them prospectively, the project aims to move beyond simplified or one-size-fits-all conclusions and instead produce a more realistic, nuanced picture of risk and resilience. In practice, this means capturing not only exposure information, but also the many biological, environmental, and social factors that can worsen outcomes or help buffer children from harm.

NIH emphasizes that the expected payoff from this work is a "deep, nuanced understanding" of the factors that influence a child's health, brain, and behavioral development. The grant frames this as a necessary foundation for later policy and program decisions: before designing effective public health strategies or supportive interventions, researchers and policymakers need clearer evidence about developmental trajectories, sensitive periods, and which co-occurring factors (such as stress, nutrition, access to care, family supports, or co-exposures) most strongly shape outcomes. In other words, this cohort is meant to create a robust evidence base that can guide future prevention approaches, clinical practices, and community-level supports aimed at improving well-being and strengthening resiliency.

Applications are sought from research teams that can credibly recruit and retain vulnerable populations over a long follow-up period, which is often one of the hardest parts of pregnancy and pediatric longitudinal research. The notice makes clear that successful applicants should have the infrastructure and expertise to conduct intensive, multi-modal assessments. These include neuroimaging components, cognitive testing, and behavioral assessments across development, paired with collection and analysis of biospecimens from both mother and baby. Taken together, these elements indicate a comprehensive approach that links brain measures, clinical and developmental outcomes, behavioral functioning, and biological markers in the same participants over time, enabling analyses that are not possible with smaller or shorter studies.

From an administrative and eligibility standpoint, this is a discretionary federal funding opportunity administered by NIH under a cooperative agreement mechanism, which typically involves substantial scientific and/or programmatic involvement from NIH staff compared with a standard research project grant. The funding opportunity lists multiple CFDA numbers (93.113, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.853), reflecting NIH program alignment across several institutes or research areas connected to substance use, child health, and brain development. The original closing date shown for this opportunity is 2021-03-31, and the opportunity record indicates it was created on 2021-01-11.

Eligibility is broad and includes many types of organizations that can support complex, longitudinal human research. Eligible applicants include state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations and tribal governments other than federally recognized entities; public housing authorities and Indian housing authorities; nonprofits (both 501(c)(3) and non-501(c)(3)); for-profit organizations other than small businesses; and small businesses. The notice also highlights categories of "other eligible applicants" that NIH is explicitly welcoming, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, U.S. territories or possessions, regional organizations, and non-U.S. (foreign) entities. This emphasis signals a strong interest in broad geographic coverage and real diversity in the cohort, as well as partnerships with institutions that are often deeply connected to communities that have been historically underrepresented in research.

Overall, the opportunity is best understood as NIH's effort to build an unusually rich, long-running dataset on prenatal and early-life substance exposure and child development, using rigorous measures (including imaging and biospecimens) while also prioritizing the real-world challenges of engaging and retaining families over many years. The expected end product is not just academic findings, but a clearer roadmap for what drives harmful outcomes versus resilience, with the longer-term aim of informing smarter, evidence-based policies and supports for children and families impacted by substance exposure.

• The National Institutes of Health in the education, environment, health sector is offering a public funding opportunity titled "HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.853.
• This funding opportunity was created on 2021-01-11.
• Applicants must submit their applications by 2021-03-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA DA 21 020

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: